Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
2.6
3.4
Journals
JPM
Special Issues
COVID-19 and Otolaryngology: Clinical Outcomes, Management, and Challenges
share announcement

Special Issue "COVID-19 and Otolaryngology: Clinical Outcomes, Management, and Challenges"

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".

Deadline for manuscript submissions: closed (20 December 2022) | Viewed by 2576

Special Issue Editor

Dr. Min Young Seo

E-Mail Website
Guest Editor
Department of Otorhinolaryngology-Head and Neck Surgery, Korea University Ansan Hospital, Korea University College of Medicine, Ansan 15355, Korea
Interests: rhinology; sleep medicine; COVID-19; endoscopic anterior skullbase surgery; particulate matter

Special Issue Information

Dear Colleagues,

After several pneumonia patients were reported to be positive for the severe acute respiratory syndrome coronavirus 2 in December 2019, it rapidly spread across the world. There have been more than 270 million confirmed cases of COVID-19, and 5.3 million deaths have been reported. In addition, a total of approximately 8.4 billion vaccine doses have been administered.

This Special Issue of the Journal of Personalized Medicine aims to highlight the current state of the global pandemic and its association with various otorhinolaryngologic diseases. Numerous cases have reported that COVID-19 infection and vaccination could induce various otorhinolaryngologic symptoms. Therefore, through this Special Issue, we would like to investigate various otorhinolaryngologic diseases related to COVID-19 and consider appropriate medical responses.

Dr. Min Young Seo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID-19
  • SARS-CoV-2
  • post-acute COVID-19 syndrome
  • COVID-19 vaccines
  • COVID-19 drug treatment
  • otorhinolaryngologic diseases

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

get_app
Article
Estimation of the Effectiveness of a Tighter, Reinforced Quarantine for the Coronavirus Disease 2019 (COVID-19) Outbreak: Analysis of the Third Wave in South Korea
by
Marn Joon Park
,
Ji Ho Choi
and
Jae Hoon Cho
J. Pers. Med. 2023, 13(3), 402; https://doi.org/10.3390/jpm13030402 - 24 Feb 2023
Viewed by 1000
Abstract
It has been claimed that a tighter, reinforced quarantine strategy was advocated to reduce the transmission of coronavirus disease 2019 (COVID-19) during major outbreaks; however, there have been no prior quantitative studies examining the effectiveness and duration of such a reinforced quarantine. Consequently, [...] Read more.
It has been claimed that a tighter, reinforced quarantine strategy was advocated to reduce the transmission of coronavirus disease 2019 (COVID-19) during major outbreaks; however, there have been no prior quantitative studies examining the effectiveness and duration of such a reinforced quarantine. Consequently, the purpose of this research was to determine the impact of a “tighter, reinforced” quarantine during the third COVID-19 breakout wave in South Korea, which occurred between late 2020 and early 2021. The efficacy of the quarantine was determined by comparing the number of newly diagnosed COVID-19 patients between the “prediction model” and “actual observed data.” Two prediction models were developed using the autoregressive integrated moving average (ARIMA; 1, 0, 0) model. The effect of a “tighter, reinforced” quarantine, which would show as an immediate drop in the number of new cases, predicted its efficacy by lowering the number of new cases by 20,400. In addition, the efficacy of the quarantine lasted up to more than three months. The findings of our investigation confirmed the beneficial influence of “tighter, controlled” quarantine laws during a widespread COVID-19 epidemic. During an epidemic, when the population has not yet developed immunity to respiratory viral diseases, our study may be evidence for implementing stricter quarantine restrictions in order to reduce the number of new cases. Full article
(This article belongs to the Special Issue COVID-19 and Otolaryngology: Clinical Outcomes, Management, and Challenges)
►▼ Show Figures

Figure 1

Review

Jump to: Research

get_app
Review
SARS-CoV-2 Infection (COVID-19) and Rhinologic Manifestation: Narrative Review
by
Seung Hoon Lee
and
Min Young Seo
J. Pers. Med. 2022, 12(8), 1234; https://doi.org/10.3390/jpm12081234 - 28 Jul 2022
Viewed by 1153
Abstract
Patients with severe pneumonia of unknown etiology presented in December 2019 in Wuhan, China. A novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was isolated from the respiratory tracts of these patients. The World Health Organization (WHO) defined respiratory diseases due to SARS-CoV-2 [...] Read more.
Patients with severe pneumonia of unknown etiology presented in December 2019 in Wuhan, China. A novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was isolated from the respiratory tracts of these patients. The World Health Organization (WHO) defined respiratory diseases due to SARS-CoV-2 infection as coronavirus disease 2019 (COVID-19). Many researchers have reported that the nasal cavity is an important initial route for SARS-CoV-2 infection and that the spike protein of this virus binds to angiotensin-converting enzyme 2 (ACE2) on epithelial cell surfaces. Therefore, COVID-19 is thought to significantly affect nasal symptoms and various rhinological diseases. In this review, we summarize the association between COVID-19 and various rhinological diseases, such as olfactory dysfunction, rhinosinusitis, and allergic rhinitis. Full article
(This article belongs to the Special Issue COVID-19 and Otolaryngology: Clinical Outcomes, Management, and Challenges)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop